International
Available Domestic
Dragon Pharma IGF-1 LR3 1 mg Long R3 Research Peptide Vial
Injection · 1 mg · vial
Dragon Pharma IGF-1 LR3 is a 1 mg lyophilized vial of the modified insulin-like growth factor, built with an arginine substitution that keeps it active far longer than the natural hormone. It acts downstream of growth hormone and is sold strictly as research material in one 1 mg size.
GMP-manufactured, HPLC-verified with the Certificate of Analysis on file. IGF-1 LR3 for sale with U.S. domestic and international shipping.
Product overview
Dragon Pharma IGF-1 LR3 1 mg Research Vial
IGF-1 LR3 is a modified insulin-like growth factor 1 with two deliberate changes: glutamic acid is replaced by arginine at position 3, and 13 extra amino acids are added, giving 83 residues against the 70 of the natural hormone. Those edits weaken its binding to the IGF binding proteins that normally mop the hormone up, so the peptide stays active for much longer than endogenous IGF-1. It sits downstream of growth hormone, which is why it appears in the same research conversations as the secretagogues.
- 1 mg lyophilized powder per vial, one pack option
- Long R3 IGF-1 analogue, 83 amino acids
- GMP-manufactured and HPLC-verified, COA per batch
- U.S. domestic and international shipping options
How IGF-1 LR3 Works
Growth hormone raises IGF-1, and IGF-1 is the signal that drives nutrient uptake, protein synthesis and cell growth in muscle and other tissue. Because the LR3 version largely escapes the binding proteins that regulate the natural factor, its effects are stronger and longer: reference material gives about 20 to 30 hours, while the same source infobox lists an elimination half-life of 56 to 72 hours, against roughly 12 to 15 hours for natural IGF-1. That disagreement is reported as a range rather than resolved. The peptide works in a different place from the Ipamorelin or GHRP-6 route, which ends upstream at growth hormone itself.
Reconstitution & Research Use
Add bacteriostatic water down the glass wall and swirl, never shake. One milligram reconstituted with 1 ml gives 1 mg/ml, so 0.1 ml holds 100 mcg and reads as 10 units on a U-100 insulin syringe; 20 to 50 mcg is therefore a very small draw and a low-dead-space syringe matters. Vendor and community material describes a single daily dose, often after training, over four to six weeks, and warns that IGF-1 sits in the same regulatory class as growth hormone. Reported class concerns are hypoglycemia, joint pain and fluid retention.
Quality & Authenticity
Each batch is produced under GMP conditions and checked by HPLC, with a Certificate of Analysis held for the batch. Keep the powder cold and dark, and do not freeze and thaw the mixed solution.
For laboratory research only. Consult a healthcare professional before use.
Specifications
| Brand | Dragon Pharma |
| Active Substance | IGF-1 LR3 |
| Dosage | 1 mg per vial |
| Package | 1 lyophilized vial |
| Form | Freeze-dried powder, requires reconstitution |
| Drug Class | Research peptide, IGF-1 analogue |
| Manufacturing | GMP-certified |
| Testing | HPLC per batch, COA on file |
| Shipping | U.S. domestic and international |
Stacks
FAQ
Before you ask
Questions, answered
It is an 83 amino acid analogue of insulin-like growth factor 1, against 70 in the natural molecule, with glutamic acid swapped for arginine at position 3 and 13 extra residues added. The changes reduce its binding to the IGF binding proteins that normally limit the natural hormone, so the analogue stays active longer and hits harder. It is a research peptide with no approved human use.
The checked source is internally inconsistent, which is worth knowing rather than hiding: the text states about 20 to 30 hours while the infobox on the same page gives an elimination half-life of 56 to 72 hours. Natural IGF-1 is described at 12 to 15 hours. The figures are quoted here as a range instead of an average, and no human study of this specific research vial exists.
Add bacteriostatic water slowly down the inside wall and swirl, never shake. One milligram with 1 ml gives 1 mg/ml, so 0.1 ml holds 100 mcg and equals 10 units on a U-100 insulin syringe. That makes community amounts of 20 to 50 mcg very small volumes, so a low-dead-space syringe and a steady hand matter more here than with a 5 mg peptide vial.
Because IGF-1 lowers blood glucose, hypoglycemia is the main concern described in community material, along with joint pain, fluid retention and injection-site reactions. No human trial of this research product exists, so nothing can be stated as a frequency. The long half-life also means an effect cannot be switched off quickly, which is a practical difference from short peptides.
The 1 mg vial is listed on this page as research material with U.S. domestic and international shipping, and price and stock appear against the option selector above. IGF-1 belongs with growth hormone and its growth factors in WADA class S2, prohibited at all times, so a tested athlete should treat the peptide as a banned substance and not as a supplement.
Be the first to share your experience with Dragon Pharma IGF-1 LR3 1 mg Long R3 Research Peptide Vial
Log in to write a reviewComplete the cycle
Stack it with
International
Available Domestic
International
International
Available Domestic